(UroToday.com) In the context of significant operative slow-downs as a result of COVID-19, there has been a renewed interest in the effect of treatment delays in urologic oncology. In a podium presentation at the American Urologic Association Virtual Annual Meeting, Dr. Devin Patel and colleagues present an analysis assessing the effect time to definitive surgical treatment on survival outcomes, stratified by tumor size in a group of young, healthy patients from the National Cancer Database (NCDB).